• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Genzyme

Genzyme

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community

    Cystic Fibrosis Foundation Celebrates FDA Approval of Orkambi as an Important Advance for the Cystic Fibrosis Community

  2. FDA Grants Breakthrough Therapy Designation for Genzyme ’s Olipudase Alfa

    FDA Grants Breakthrough Therapy Designation for Genzyme ’s Olipudase Alfa

  3. Isis Pharmaceuticals to Present a General Corporate Update at its 2015 Annual Meeting of Stockholders and Open House

    Isis Pharmaceuticals to Present a General Corporate Update at its 2015 Annual Meeting of Stockholders and Open House

  4. Alnylam Reports New Positive Clinical Data for ALN-AT3, a Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding ...

    Alnylam Reports New Positive Clinical Data for ALN-AT3, a Subcutaneously Administered, Investigational RNAi Therapeutic Targeting Antithrombin (AT) for the Treatment of Hemophilia and Rare Bleeding Disorders

  5. Global Genes to Host Fourth Annual Tribute to Champions of Hope Gala and Patient Advocacy Summit

    Global Genes to Host Fourth Annual Tribute to Champions of Hope Gala and Patient Advocacy Summit

  6. REITs, Target Dates, Dollar-Proofing, and More

    A roundup of investment news.

  7. High-Confidence Stock Picks

    Focusing on stocks with the most visible cash flows has been a winning strategy, and this screen can find them.

  8. Early Favorites for Manager of the Year--Domestic Stock

    Who's in front heading 'round the bend?

  9. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

123
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.